RAPT Insider Trading Activity and SEC Form 4 Filings
RAPT insider trading summary
No open-market insider purchases or sales of RAPT Therapeutics, Inc. (RAPT) have been reported on SEC Form 4 in the past 12 months.
Latest RAPT insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jan 5, 2024 | Dirk G. Brockstedt | Chief Scientific Officer | Sell | $20K (898 @ $22.78) |
| Dec 21, 2023 | William Ho | Chief Medical Officer | Sell | $54K (2,500 @ $21.68) |
| Nov 28, 2023 | William Ho | Chief Medical Officer | Sell | $21K (1,500 @ $13.72) |
| Oct 3, 2023 | William Ho | Chief Medical Officer | Sell | $39K (2,500 @ $15.77) |
| Aug 18, 2023 | William Ho | Chief Medical Officer | Sell | $47K (2,500 @ $18.92) |
| Apr 19, 2023 | William Ho | Chief Medical Officer | Sell | $94K (5,000 @ $18.88) |
| Mar 14, 2023 | Wendye Robbins | Director | Buy | $7K (400 @ $18.48) |
| Mar 14, 2023 | Wendye Robbins | Director | Buy | $28K (1,500 @ $18.75) |
| Mar 14, 2023 | Wendye Robbins | Director | Buy | $12K (600 @ $19.95) |
| Mar 14, 2023 | Wendye Robbins | Director | Buy | $50K (2,500 @ $20.05) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.